类风湿关节炎持续缓解与低疾病活动度患者的患者报告结局及影像学进展比较
该研究基于治疗至目标的多中心随机对照试验,比较首年达到持续缓解、持续低疾病活动度或活动性疾病患者5年内的患者报告结局及2年影像学进展。结果显示持续缓解组疼痛、疲劳、功能、健康相关生活质量及生产力损失均优于持续低疾病活动度组,活动性疾病组差异更大(SF-36 MCS和EQ-5D-3L除外),但组间改良总Sharp评分无差异。
要点
- 首年持续缓解者随访期间疼痛、疲劳、功能及生活质量优于持续低疾病活动度者
- 活动性疾病组与持续缓解组差异更大,但SF-36 MCS和EQ-5D-3L除外
- 各组间2年改良总Sharp评分无差异
主要发现
- 持续低疾病活动度组较持续缓解组:疼痛(0-10 Likert量表)高0.90单位(95%CI 0.52至1.27),疲劳(视觉模拟量表)高12.10单位(95%CI 7.27至16.92),功能损害(健康评估问卷残疾指数)高0.28单位(95%CI 0.17至0.39)。
- 持续低疾病活动度组较持续缓解组:躯体健康相关生活质量(SF-36躯体成分汇总评分)低4.42单位(95%CI -6.39至-2.45),精神健康相关生活质量(SF-36精神成分汇总评分)低2.95单位(95%CI -4.83至-1.07)。
- 持续低疾病活动度组较持续缓解组:健康状况(EQ-5D-3L)低0.06单位(95%CI -0.09至-0.03),生产力损失(0%-100%)高7.76%(95%CI 2.76至12.75)。
- 活动性疾病组与持续缓解组差异更大,但SF-36精神成分汇总评分和EQ-5D-3L除外。
- 各组间改良总Sharp评分无差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare clinical and patient-reported outcomes (PROs) over 5 years between patients with rheumatoid arthritis (RA) in sustained remission (sREM), sustained low disease activity (sLDA) or active disease (AD) in the first year after diagnosis. METHODS: All patients with RA from the treatment in the Rotterdam Early Arthritis CoHort trial, a multicentre, stratified, single-blinded trial with a treat-to-target approach, aiming for LDA (Disease Activity Score (DAS) ≤2.4), were studied. Patients were categorised into: (1) sREM (mean DAS from 6 to 12 months <1.6) (n=173); (2) sLDA (mean DAS from 6 to 12 months 1.6-2.4) (n=142); and (3) AD (mean DAS from 6 to 12 months >2.4) (n=59). Pain, fatigue, functional impairment, health-related quality of life (HRQoL), health status and productivity loss during 5 years were compared between groups. Radiographic progression (modified Total Sharp Score (mTSS)) was compared over 2 years. RESULTS: Patients in sLDA in the first year had worse PROs during follow-up, compared with patients in sREM: pain (0-10 Likert) was 0.90 units higher (95% CI 0.52 to 1.27), fatigue (Visual Analogue Scale) was 12.10 units higher (95% CI 7.27 to 16.92), functional impairment (Health Assessment Questionnaire-Disability Index) was 0.28 units higher (95% CI 0.17 to 0.39), physical HRQoL (36-item Short Form Health Survey (SF-36) Physical Component Summary score) was 4.42 units lower (95% CI -6.39 to -2.45), mental HRQoL (SF-36 Mental Component Summary score (MCS)) was 2.95 units lower (95% CI -4.83 to -1.07), health status (European Quality of life 5-Dimensions 3-Levels (EQ-5D-3L)) was 0.06 units lower (95% CI -0.09 to -0.03) and productivity loss (0%-100%) was 7.76% higher (95% CI 2.76 to 12.75). Differences between the AD and sREM group were even larger, except for the SF-36 MCS and EQ-5D-3L. No differences in mTSS were found between groups. CONCLUSION: Patients with RA who reach sREM in the first year have better HRQoL and function, and less pain, fatigue and productivity loss in the years thereafter, compared with patients with RA who are in sLDA or AD in the first year.
引用
- Snoeck Henkemans SVJ, Vis M, Looijen AEM, et al. Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activity. RMD Open. 2024. PMID: 38382943. doi:10.1136/rmdopen-2023-003860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。